XML 38 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Aug. 31, 2024
Aug. 26, 2023
Aug. 27, 2022
Operating Activities      
Net income $ 13,000,000.0 $ 215,900,000 $ 390,600,000
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation 35,600,000 29,200,000 24,200,000
Amortization 23,000,000.0 17,700,000 29,400,000
Non-cash interest expense, net 0 0 15,100,000
Amortization of debt issuance costs 3,200,000 3,100,000 2,500,000
Last in, first-out ("LIFO") expense 4,200,000 500,000 8,400,000
Stock-based compensation 14,600,000 10,900,000 17,100,000
Deferred income taxes 8,100,000 16,300,000 (6,700,000)
Deferred compensation expense 900,000 700,000 500,000
Goodwill impairment (Note 7) 30,300,000 0 0
Loss on note repurchase (Note 9) 32,700,000 0 0
Contingent consideration fair value adjustment 1,100,000 600,000 29,400,000
Payments of earnout liability above acquisition-date fair value (14,700,000) (13,300,000) 0
Other, net 5,400,000 800,000 1,900,000
Change in operating assets and liabilities, net of assets and liabilities acquired      
Receivables, net (5,200,000) 76,700,000 1,900,000
Inventories, net 27,200,000 63,800,000 (171,300,000)
Prepaid expenses and other assets 1,700,000 9,700,000 1,200,000
Accounts payable (3,900,000) (67,500,000) 27,200,000
Income taxes and unrecognized tax benefits 5,000,000.0 (8,900,000) (7,400,000)
Accrued expenses and other liabilities (38,300,000) (61,700,000) 36,600,000
Net cash provided by operating activities 143,900,000 294,500,000 400,600,000
Investing activities      
Purchases of property, plant, and equipment (45,000,000.0) (83,200,000) (88,000,000.0)
Acquisition of business, net of cash acquired 0 (87,500,000) (228,200,000)
Proceeds from the sale of property, plant, and equipment 400,000 400,000 200,000
Other, net (1,300,000) 300,000 300,000
Net cash used in investing activities (45,900,000) (170,000,000.0) (315,700,000)
Financing activities      
Borrowings on long-term debt 2,652,200,000 3,718,000,000 4,735,600,000
Repayments on long-term debt (2,596,000,000) (3,718,000,000) (4,735,600,000)
Payments for convertible note bond hedge (68,700,000) 0 0
Proceeds from issuance of convertible note warrant 31,300,000 0 0
Proceeds from partial unwind of convertible note bond hedge 55,800,000 0 0
Payments for partial unwind of convertible note warrant (25,300,000) 0 0
Payments of cash dividends (36,800,000) (33,200,000) (23,800,000)
Payments for repurchases of common stock (74,500,000) (55,100,000) (214,300,000)
Payments of debt issuance costs (10,400,000) 0 (1,200,000)
Payments of earnout liability up to acquisition-date fair value (5,800,000) (8,700,000) 0
Other, net 1,200,000 200,000 2,000,000.0
Net cash used in financing activities (77,000,000.0) (96,800,000) (237,300,000)
Net increase/(decrease) in cash and cash equivalents 21,000,000.0 27,700,000 (152,400,000)
Cash and cash equivalents at beginning of period 309,900,000 282,200,000 434,600,000
Cash and cash equivalents at end of period 330,900,000 309,900,000 282,200,000
Supplemental Disclosures      
Income taxes paid, net 14,400,000 57,800,000 139,700,000
Interest paid 29,000,000.0 24,200,000 23,800,000
Non-cash investing and financing activities      
Issuance of common stock for acquisition of business 0 0 22,000,000.0
Issuance of common stock for settlement of earnout liability 0 0 13,200,000
Capital expenditures in accounts payable 4,600,000 3,000,000.0 6,800,000
Dividends declared not yet paid 10,900,000 10,200,000 8,800,000
Increase in lease assets in exchange for lease liabilities:      
Operating leases 9,800,000 5,600,000 17,200,000
Financing leases $ 1,800,000 $ 2,400,000 $ 2,500,000